$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?

In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise. Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/ Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them. Subscribe for more episodes: https://www.youtube.com/@AcquisitionsAnonymousPodcast?sub_confirmation=1 Subscribe to our Newsletter: https://www.acquanon.com/newsletter Connect with us on Social Media: Twitter: https://twitter.com/acquanon LinkedIn: https://www.linkedin.com/company/acquanon 👋 Follow the Hosts Michael Girdley – Entrepreneur & investor. Twitter: https://twitter.com/girdley Bill D’Alessandro – CEO of Elements Brands. Twitter: https://twitter.com/BillDA Heather Endresen – SBA lending expert & advisor. Twitter: https://twitter.com/EndresenHeather Mills Snell – Small business investor & advisor. Twitter: https://twitter.com/thegeneralmills 💰 Sponsored by: Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week. Key Highlights: - Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin) - Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market - Opportunity for U.S. expansion + licensing of characters/brands to build a moat - Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables - Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin